Cutia Therapeutics's market cap is currently HK$2.73B. The company's EPS TTM is HK$-0.8164900500000001; its P/E ratio is ―; Cutia Therapeutics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
